Listed

Optex Systems Holdings Inc: Form 10-Q for the period ended Jul 2, 2023

Filed with the SEC on Aug 16, 2023 and accepted by EDGAR at Aug 16, 2023, 16:00 ET.

Share

Management's discussion and analysis

As filed, 49,190 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to supplement and complement our audited consolidated financial statements and notes thereto for the fiscal year ended October 2, 2022 and our unaudited condensed consolidated financial statements and notes thereto for the quarter ended July 2, 2023, prepared in accordance with U.S. generally accepted accounting principles (GAAP). You are encouraged to review our consolidated financial statements in conjunction with your review of this MD&A. The financial information in this MD&A has been prepared in accordance with GAAP, unless otherwise indicated. In addition, we use non-GAAP financial measures as supplemental indicators of our operating performance and financial position. We use these non-GAAP financial measures internally for comparing actual results from one period to another, as well as for planning purposes. We will also report non-GAAP financial results as supplemental information, as we believe their use provides more insight into our performance. When a non-GAAP measure is used in this MD&A, it is clearly identified as a non-GAAP measure and reconciled to the most closely corresponding GAAP measure.

The following discussion highlights the principal factors that have affected our financial condition and results of operations as well as our liquidity and capital resources for the periods described. The operating results for the periods presented were not significantly affected by inflation.

Cautionary Note Regarding Forward-Looking Information

This Quarterly Report on Form 10-Q, in particular the MD&A, contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements contained in this Quarterly Report on Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. When used in this Quarterly Report on Form 10-Q and other reports, statements, and information we have filed with the Securities and Exchange Commission (“Commission” or “SEC”), in our press releases, presentations to securities analysts or investors, or in oral statements made by or with the approval of an executive officer, the words or phrases “believes,” “may,” “will,” “expects,” “should,” “continue,” “anticipates,” “intends,” “will likely result,” “estimates,” “projects” or similar expressions and variations thereof are intended to identify such forward-looking statements.

These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding growth strategy; product and development programs; financial performance and financial condition (including revenue, net income, profit margins and working capital); orders and backlog; expected timing of contract deliveries to customers and corresponding revenue recognition; increases in the cost of materials and labor; costs remaining to fulfill contracts; contract loss reserves; labor shortages; follow-on orders; the impact of the COVID-19 pandemic; supply chain challenges; the continuation of historical trends; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our plans for future operations; and the economy in general or the future of the defense industry.

We caution that these statements by their nature involve risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. Such risks and uncertainties include, but are not limited to, continued funding of defense programs and military spending, the timing of such funding, general economic and business conditions, including unforeseen weakness in the Company’s markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, changes in the U.S. Government’s interpretation of federal procurement rules and regulations, changes in spending due to policy changes in any new federal presidential administration, market acceptance of the Company’s products, shortages in components, production delays due to performance quality issues with outsourced components, inability to fully realize the expected benefits from acquisitions and restructurings or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, changes to export regulations, increases in tax rates, changes to generally accepted accounting principles, difficulties in retaining key employees and customers, unanticipated costs under fixed-price service and system integration engagements, changes in the market for microcap stocks regardless of growth and value and various other factors beyond our control. Some of these risks and uncertainties are identified in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and the section “Risk Factors” in our Annual Report on Form 10-K and you are urged to review those sections. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.

We do not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K.

Background

Optex Systems, Inc. (Delaware) manufactures optical sighting systems and assemblies, primarily for Department of Defense applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and armored security vehicles and have been selected for installation on the Stryker family of vehicles. Optex Systems, Inc. (Delaware) also manufactures and delivers numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Optex Systems, Inc. (Delaware) products consist primarily of build-to-customer print products that are delivered both directly to the armed services and to other defense prime contractors. Less than 1% of today’s revenue is related to the resale of products substantially manufactured by others. In this case, the product would likely be a simple replacement part of a larger system previously produced by Optex Systems, Inc. (Delaware).

We are both a prime and sub-prime contractor to the Department of Defense. Sub-prime contracts are typically issued through major defense contractors such as General Dynamics Land Systems, Raytheon Corp., BAE, ADS Inc. and others. We are also a military supplier to foreign governments such as Israel, Australia and South American countries and as a subcontractor for several large U.S. defense companies serving foreign governments.

The Federal Acquisition Regulation is the principal set of regulations that govern the acquisition process of government agencies and contracts with the U.S. government. In general, parts of the Federal Acquisition Regulation are incorporated into government solicitations and contracts by reference as terms and conditions effecting contract awards and pricing solicitations.

Many of our contracts are prime or subcontracted directly with the Federal government and, as such, are subject to Federal Acquisition Regulation Subpart 49.5, “Contract Termination Clauses” and more specifically Federal Acquisition Regulation clauses 52.249-2 “Termination for Convenience of the Government (Fixed-Price)”, and 49.504 “Termination of fixed-price contracts for default”. These clauses are standard clauses on our prime military contracts and generally apply to us as subcontractors. It has been our experience that the termination for convenience is rarely invoked, except where it is mutually beneficial for both parties. We are currently not aware of any pending terminations for convenience or for default on our existing contracts.

In the event a termination for convenience were to occur, Federal Acquisition Regulation clause 52.249-2 provides for full recovery of all contractual costs and profits reasonably occurred up to and as a result of the terminated contract. In the event a termination for default were to occur, we could be liable for any excess cost incurred by the government to acquire supplies from another supplier similar to those terminated from us. We would not be liable for any excess costs if the failure to perform the contract arises from causes beyond the control and without the fault or negligence of the Company as defined by Federal Acquisition Regulation clause 52.249-8.

In addition, some of our contracts allow for government contract financing in the form of contract progress payments pursuant to Federal Acquisition Regulation 52.232-16, “Progress Payments”. As a small business, and subject to certain limitations, this clause provides for government payment of up to 90% of incurred program costs prior to product delivery. To the extent our contracts allow for progress payments, we intend to utilize this benefit, thereby minimizing the working capital impact on Optex Systems Holdings for materials and labor required to complete the contracts.

Recent Events

May 2023 Grants

On May 9, 2023, the Board of Directors approved a grant of 40,000 shares of restricted stock to independent board member Dayton Judd. The shares vest 50% on each of January 1, 2024 and January 1, 2025. As of the grant date, the fair value of the shares was $124 thousand, to be amortized on a straight-line basis through December 31, 2024.

On May 3, 2023, the Board of Directors approved a grant of 100,000 and 35,000 performance shares to Danny Schoening, CEO, and Karen Hawkins, CFO, respectively. Each performance share represents a contingent right to receive one share of common stock. The performance shares vest in five equal increments if, in each case and during a five-year performance period beginning on October 2, 2023, the average VWAP per share of common stock over a 30 consecutive trading day period equals or exceeds $3.70, $4.45, $5.35, $6.40, or $7.70. The fair value of the shares as of the grant date was $320 thousand and will be amortized through December 31, 2025 based on the derived service periods using a Monte Carlo simulation valuation model.

On May 1, 2023, the Company granted an aggregate of 39,000 restricted stock units to eleven employees under its 2023 Equity Incentive Plan. The restricted stock units will vest at a rate of 33.33% annually on the anniversary date of the grant and any unvested restricted stock units will be forfeited if employment terminates prior to the relevant vesting date. As of the grant date, assuming a 23.1% forfeiture rate based on expected turnover across the three years, the aggregate value of the restricted stock units is $90 thousand which will be amortized across the three-year period on a straight-line basis. During the three months ended July 2, 2023, there were 3,000 restricted stock units forfeited.

Texas Capital Credit Facility

On March 22, 2023, the Company and its subsidiary, Optex Systems, Inc. (“Optex”, and with the Company, the “Borrowers”), entered into a Business Loan Agreement (the “Loan Agreement”) with Texas Capital Bank (the “Lender”), pursuant to which the Lender will make available to the Borrowers a revolving line of credit in the principal amount of $3 million (the “Credit Facility”). The commitment period for advances under the Credit Facility is twenty-six months expiring on May 22, 2025. We refer to the expiration of that time period as the “Maturity Date.” Outstanding advances under the Credit Facility will accrue interest at a rate equal to the secured overnight financing rate (SOFR) plus a specified margin, subject to a specified floor interest rate. The interest rate is currently at 7.501% per annum.

The Loan Agreement contains customary events of default (including a 25% change in ownership) and negative covenants, including but not limited to those governing indebtedness, liens, fundamental changes (including changes in management), investments, and restricted payments (including cash dividends). The Loan Agreement also requires the Borrowers to maintain a fixed charge coverage ratio of at least 1.25:1 and a total leverage ratio of 3.00:1. The Credit Facility is secured by substantially all of the operating assets of the Borrowers as collateral. The Borrowers’ obligations under the Credit Facility are subject to acceleration upon the occurrence of an event of default as defined in the Loan Agreement. The Loan Agreement further provides for a $125 thousand Letter of Credit sublimit.

The Credit Facility replaced the prior $2 million line of credit with PNC Bank, National Association.

NASDAQ Listing

On March 14, 2023, the Company’s shares of common stock were listed on the NASDAQ Capital Market under the ticker symbol “OPXS.”

2023 Equity Incentive Plan

On February 16, 2023, the Company’s shareholders approved the Company’s 2023 Equity Incentive Plan (the “2023 Plan”), under which 600,000 shares of common stock are reserved for issuance. The 2023 Plan permits the grant of stock options, performance shares, performance units, restricted stock, restricted stock units and stock appreciation rights to officers, other employees, individuals engaged to become officers or employees, consultants, advisors and non-executive directors of the Company. In connection with the approval of the 2023 Plan, the Company’s 2016 Restricted Stock Unit Plan and 2009 Stock Option Plan were both canceled.

Material Trends

Recent supply chain disruptions have strained our suppliers and extended supplier delivery lead times, affecting their ability to sustain operations. We anticipate market wide material shortages for paint and resin products as well as critical epoxies and chemicals used in our manufacturing process. In addition, we are seeing substantial increases in the costs of aluminum, steel and acrylic commodities, which has affected our net income in the first nine months of fiscal year 2023 and is expected to continue to have a negative effect on the margins expected to be generated under our long-term fixed contracts over the next three years.

We have experienced significant material shortages during the three months ended October 2, 2022 and extending into the first nine months of fiscal year 2023 from two significant suppliers of our periscope covers and housings. These shortages affect several of our periscope products at the Optex Richardson segment. The delays in key components, combined with labor shortages during the first nine months of fiscal year 2023, have negatively impacted our production levels and have pushed expected customer delivery dates into the first half of fiscal year 2024. We are aggressively seeking alternative sources and actively expediting our current suppliers for these components as well as increasing employee recruitment initiatives and overtime to attempt to mitigate any continuing risks to the periscope line. In addition, one of our major customers for the Applied Optics Center requested a significant schedule delay pushing their laser filter unit deliveries from the first half into the second half of fiscal year 2023. We are encouraged by recent improvements in supplier performance for the Optex Richardson segment periscope line which yielded increased revenue performance during the second and third quarters. However, we cannot give any assurances that expected customer delivery dates for our periscope products will not need to be delayed further.

In March 2023, we moved our line of credit from PNC Bank to Texas Capital Bank and increased our available line of credit to $3.0 million from the previous $2.0 million line with PNC. The increase in credit limit helps us meet our working capital requirements in light of the increased backlog and delay of revenues from the first nine months of fiscal year 2023. As supplier issues and labor shortages continue to abate, we anticipate increased revenue and working capital in the fourth quarter of fiscal year 2023 and continuing into fiscal year 2024. Based on our current backlog, we anticipate an overall increase for fiscal year 2023 revenues as compared to the 2022 levels.

We refer also to “Item 1. Business – Market Opportunity: U.S. Military” in our annual report on Form 10-K for the year ended October 2, 2022 for a description of current trends in U.S. government military spending and its potential impact on Optex, which may be material, including particularly the tables included in that section and disclosure on the significant reduction in spending for U.S ground system military programs, which has a direct impact on the Optex Systems Richardson segment revenue, all of which is incorporated herein by reference.

Results of Operations

Non-GAAP Adjusted EBITDA

We use adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) as an additional measure for evaluating the performance of our business as “net income” includes the significant impact of noncash valuation gains and losses on warrant liabilities, noncash compensation expenses related to equity stock issues, as well as depreciation, amortization, interest expenses and federal income taxes. We believe that Adjusted EBITDA is a meaningful indicator of our operating performance because it permits period-over-period comparisons of our ongoing core operations before the excluded items, which we do not consider relevant to our operations. Adjusted EBITDA is a financial measure not required by, or presented in accordance with, U.S. generally accepted accounting principles (“GAAP”).

Adjusted EBITDA has limitations and should not be considered in isolation or a substitute for performance measures calculated under GAAP. This non-GAAP measure excludes certain cash expenses that we are obligated to make. In addition, other companies in our industry may calculate Adjusted EBITDA differently than we do or may not calculate it at all, which limits the usefulness of Adjusted EBITDA as a comparative measure.

The table below summarizes our three-and six-month operating results for the periods ended July 2, 2023 and July 3, 2022, in terms of both the GAAP net income measure and the non-GAAP Adjusted EBITDA measure. We believe that including both measures allows the reader better to evaluate our overall performance.

(Thousands) Three months ended July 2, 2023 July 3, 2022 Nine months ended July 2, 2023 July 3, 2022
Net Income (GAAP) $576 $428 $832 $306
Add:
Federal Income Tax Expense 154 82 223 28
Depreciation 86 74 252 221
Stock Compensation 81 36 134 127
Interest Expense 22 - 31 -
Adjusted EBITDA - Non GAAP $919 $620 $1,472 $682

Our net income increased by $0.2 million to $0.6 million for the three months ended July 2, 2023, as compared to net income of $0.4 million for the prior year period. Our adjusted EBITDA increased by $0.3 million to $0.9 million for the three months ended July 2, 2023, as compared to $0.6 million for the prior year period.

Our net income increased by $0.5 million to $0.8 million for the nine months ended July 2, 2023, as compared to a net income of $0.3 million for the prior year period. Our adjusted EBITDA increased by $0.8 million to $1.5 million for the nine months ended July 2, 2023, as compared to $0.7 million for the prior year period.

The increase in the most recent three and nine-month period net income and adjusted EBITDA is primarily driven by higher revenue across both operating segments and significantly improved gross profit performance in the Applied Optics Center segment, which was only partially offset by poorer performance in the Optex segment. Operating segment performance is discussed in greater detail throughout the following sections.

Results of Operations Selective Financial Information (Thousands) Three months ended July 2, 2023 Optex Richardson Applied Optics Center Dallas Other (non-allocated costs and eliminations) Consolidated July 3, 2022 Optex Richardson Applied Optics Center Dallas Other (non-allocated costs and eliminations) Consolidated
Revenue from External Customers $3,069 4,103 - 7,172 $2,653 $3,517 $- $6,170
Intersegment Revenues - 265 (265) - - 258 (258) -
Total Segment Revenue 3,069 4,368 (265) 7,172 2,653 3,775 (258) 6,170
Total Cost of Sales 2,757 2,968 (265) 5,460 2,125 3,035 (258) 4,902
Gross Profit 312 1,400 - 1,712 528 740 - 1,268
Gross Margin % 10.2% 32.1% - 23.9% 19.9% 19.6% - 20.6%
General and Administrative Expense 758 121 81 960 611 111 36 758
Segment Allocated G&A Expense (386) 386 - - (268) 268 - -
Net General & Administrative Expense 372 507 81 960 343 379 36 758
Operating Income (Loss) (60) 893 (81) 752 185 361 (36) 510
Operating Income (Loss) % (2.0)% 20.4% - 10.5% 7.0% 9.6% - 8.3%
Interest Expense - - 22 22 - - - -
Net Income (Loss) before taxes $(60) 893 (103) 730 $185 $361 $(36) $510
Net Income (Loss) % (2.0)% 20.4% - 10.2% 7.0% 9.6% - 8.3%

7

Results of Operations Selected Financial Info by Segment (Thousands) Nine months ended July 2, 2023 Optex Richardson Applied Optics Center Dallas Other (non-allocated costs and eliminations) Consolidated July 3, 2022 Optex Richardson Applied Optics Center Dallas Other (non-allocated costs and eliminations) Consolidated
Revenue from External Customers $7,742 9,840 - 17,582 $6,588 $9,057 $- $15,645
Intersegment Revenues - 511 (511) - - 693 (693) -
Total Segment Revenue 7,742 10,351 (511) 17,582 6,588 9,750 (693) 15,645
Total Cost of Sales 6,830 7,280 (511) 13,599 5,695 7,836 (693) 12,838
Gross Profit 912 3,071 - 3,983 893 1,914 - 2,807
Gross Margin % 11.8% 29.7% - 22.7% 13.6% 19.6% - 17.9%
General and Administrative Expense 2,417 346 134 2,897 1,971 375 127 2,473
Segment Allocated G&A Expense (978) 978 - - (802) 802 - -
Net General & Administrative Expense 1,439 1,324 134 2,897 1,169 1,177 127 2,473
Operating Income (Loss) (527) 1,747 (134) 1,086 (276) 737 (127) 334
Operating Income (Loss) % (6.8)% 16.9% - 6.2% (4.2)% 7.6% - 2.1%
Interest Expense - - 31 31 - - - -
Income (Loss) before taxes $(527) 1,747 (165) (1,055) $(276) $737 $(127) $334
Income (loss) before taxes % (6.8)% 16.9% - 6.0% (4.2)% 7.6% - 2.1%

For the three months ended July 2, 2023, our total revenues increased by $1.0 million, or 16.2%, compared to the prior year period. For the nine months ended July 2, 2023, our total revenues increased by $1.9 million, or 12.4%, compared to the prior year period. The increase in revenue for the three and nine-month periods were driven by increased sales across both segments as compared to the prior year.

Consolidated gross profit for the three months ended July 2, 2023 increased by $0.4 million, or 35.0%, compared to the prior year period. Consolidated gross profit for the nine months ended July 2, 2023 increased by $1.2 million, or 41.9%, compared to the prior year period. The increase in the most recent three and nine-month period gross profit was primarily attributable to (1) higher revenue spread across a fixed manufacturing cost base combined with changes in product mix and improved pricing and operating performance in our Applied Optics optical assembly line, (2) partially offset by lower profit margins on our Optex segment driven by inflationary pressures on our long-term fixed price contracts.

Our operating income for the three months ended July 2, 2023 increased by $0.2 million, or 47.5%, compared to the prior year period. Our operating income for the nine months ended July 2, 2023 increased by $0.8 million, or 225.1%, compared to the prior year period. The increase in operating income for the three and nine-month periods was primarily driven by higher revenue and increased gross profit in the Applied Optics Center segment.

New Orders and Backlog

Product backlog represents the value of unfulfilled customer manufacturing orders yet to be recognized as revenue. While backlog is not a non-GAAP financial measure, it is also not defined by GAAP. Therefore, our methodology for calculating backlog may not be consistent with methodologies used by other companies. The booked backlog by period may also not be fully indicative of the predicted revenues for those periods as many of our orders provide for accelerated delivery without penalty and may additionally provide customers the option to adjust schedules to meet their most recent projected demand quantities. However, we provide customer order and backlog information as we believe it provides significant insight into forward demand, with some predictive power to short term future revenues.

During the nine months ended July 2, 2023, the Company booked $26.3 million in new orders, representing a 43.7% increase over the prior year period. The orders for the most recently completed nine months consist of $18.6 million for our Optex Richardson segment and $7.7 million attributable to the Applied Optics Center segment.

The following table depicts the new customer orders for the nine months ending July 2, 2023 as compared to the prior year period in millions of dollars:

Product Line (Millions) Nine months ended July 2, 2023 Nine months ended July 3, 2022 Variance % Chg
Periscopes $11.6 $6.8 $4.8 70.6%
Sighting Systems 4.0 0.6 3.4 566.7%
Howitzer - - - -%
Other 3.0 2.4 0.6 25.0%
Optex Systems – Richardson 18.6 9.8 8.8 89.8%
Optical Assemblies 1.2 3.8 (2.6) (68.4)%
Laser Filters 5.5 3.2 2.3 71.9%
Day Windows 0.1 0.6 (0.5) (83.3)%
Other 0.9 0.9 - -%
Applied Optics Center – Dallas 7.7 8.5 (0.8) (9.4)%
Total Customer Orders $26.3 $18.3 $8.0 43.7%

The Company has seen significant increases in orders for many of its defense products during the first nine months of fiscal year 2023 inclusive of two new customers for our sighting systems and filter programs. On November 1, 2022, the Company announced it has been awarded a $3.4 million order to repair and refurbish night vision equipment for the Government of Israel. The order represents a significant increase in our Optex Richardson sighting systems business base for a new customer and includes an additional potential award value with a 100% optional award quantity clause. Deliveries under this contract are expected to begin in the first quarter of fiscal year 2024. On June 30, 2023, we booked a $3.0 million delivery order at our Applied Optics segment for the delivery of laser interface filters against a five-year IDIQ contract. Our periscope orders for the Optex segment have increased significantly over the prior year period including $7.2 million in task delivery awards against our long term IDIQ contracts during the nine-month period.

Backlog as of July 2, 2023, was $41.6 million as compared to a backlog of $30.0 million as of July 3, 2022, representing an increase of $11.6 million or 38.7%. The following table depicts the current expected delivery by period of all contracts awarded as of July 2, 2023 in millions of dollars, as well as the July 2, 2023 backlog as compared to the backlog on July 3, 2022:

Product Line (Millions) Q4 2023 Delivery 2024 Delivery 2025+ Delivery Total Backlog 7/2/2023 Total Backlog 7/3/2022 Variance % Chg
Periscopes $2.5 $9.0 $1.6 $13.1 $7.6 $5.5 72.4%
Sighting Systems 0.5 2.6 2.1 5.2 1.8 3.4 188.9%
Howitzer - 1.1 1.2 2.3 2.3 - -%
Other 0.7 4.0 0.8 5.5 2.5 3.0 120.0%
Optex Systems - Richardson 3.7 16.7 5.7 26.1 14.2 11.9 83.8%
Optical Assemblies 1.1 2.2 - 3.3 5.5 (2.2) (40.0)%
Laser Filters 2.3 5.9 1.6 9.8 8.9 0.9 10.1%
Day Windows 0.3 0.9 0.6 1.8 0.8 1.0 125.0%
Other 0.1 0.3 0.2 0.6 0.6 - -%
Applied Optics Center - Dallas 3.8 9.3 2.4 15.5 15.8 (0.3) (1.9)%
Total Backlog $7.5 $26.0 $8.1 $41.6 30.0 11.6 38.7%

Optex Systems Richardson backlog as of July 2, 2023, was $26.1 million as compared to a backlog of $14.2 million as of July 3, 2022, representing an increase of $11.9 million or 83.8%.

Applied Optics Center backlog as of July 3, 2022, was $15.5 million as compared to a backlog of $15.8 million as of July 3, 2022, representing a decrease of ($0.3) million or (1.9%).

Please refer to “—Recent Events” and “Material Trends” above or “Liquidity and Capital Resources” below for more information on recent developments and trends with respect to our orders and backlog, which information is incorporated herein by reference.

The Company continues to pursue domestic, international and commercial opportunities in addition to maintaining its current footprint with U.S. vehicle manufactures, with existing as well as new product lines. We are also reviewing potential products outside our traditional product lines, which could be manufactured using our current production facilities in order to capitalize on our existing excess capacity.

Three Months Ended July 2, 2023 Compared to the Three Months Ended July 3, 2022

Revenue. For the three months ended July 2, 2023, revenue increased by $1.0 million or 16.2% compared to the prior year period as set forth in the table below:

Product Line Three months ended (Thousands) July 2, 2023 July 3, 2022 Variance % Chg
Periscopes $2,623 $2,296 $327 14.2
Sighting Systems 137 192 (55) (28.6)
Howitzers - - - -
Other 309 165 144 87.3
Optex Systems - Richardson 3,069 2,653 416 15.7
Optical Assemblies 1,452 1,310 142 10.8
Laser Filters 2,286 1,693 593 35.0
Day Windows 120 169 (49) (29.0)
Other 245 345 (100) (29.0)
Applied Optics Center - Dallas 4,103 3,517 586 16.7
Total Revenue $7,172 $6,170 $1,002 16.2

10

Optex Systems Richardson revenue increased by $0.4 million or 15.7% for the three months ended July 2, 2023 as compared to the prior year period on increased revenue volume from periscopes and other, partially offset by a reduction in sighting systems volume.

Applied Optics Center revenue increased by $0.6 million or 16.7% for the three months ended July 2, 2023 as compared to the prior year period. The revenue increase is primarily attributable to increased delivery volume of laser filters and optical assemblies.

Gross Margin. The gross margin during the three-month period ended July 2, 2023 was 23.9% of revenue as compared to a gross margin of 20.6% of revenue for the prior year period. The increase in gross profit is primarily attributable to higher revenue, changes in product mix between segments, and increased absorption of fixed overhead across a higher revenue mix (on a consolidated company basis) . Cost of sales increased to $5.5 million for the current period as compared to the prior year period of $4.9 million on higher revenue.

G&A Expenses. During the three months ended July 2, 2023 and July 3, 2022, we recorded operating expenses of $1.0 million and $0.8 million, respectively. Operating expenses increased by 26.6% between the respective periods primarily due to increased labor, office, legal, accounting and banking, stock compensation and travel expenses.

Operating Income. During the three months ended July 2, 2023, we recorded operating income of $0.8 million, as compared to operating income of $0.5 million during the three months ended July 3, 2022. The $0.3 million increase in operating income for the current year period from the prior year period is primarily due to increased revenue and gross profit, offset by higher spending in general and administrative expenses.

Nine months Ended July 2, 2023 Compared to the Nine months Ended July 3, 2022

Revenues. For the nine months ended July 2, 2023, revenues increased by $1.9 million or 12.4% compared to the prior year period as set forth in the table below:

Product Line Nine months ended (Thousands) July 2, 2023 July 3, 2022 Variance % Chg
Periscopes $6,085 $4,924 $1,161 23.6
Sighting Systems 464 642 (178) (27.7)
Howitzers - - - -
Other 1,193 1,022 171 16.7
Optex Systems - Richardson 7,742 6,588 1,154 17.5
Optical Assemblies 4,438 3,285 1,153 35.1
Laser Filters 4,404 4,154 250 6.0
Day Windows 350 809 (459) (56.7)
Other 648 809 (161) (19.9)
Applied Optics Center - Dallas 9,840 9,057 783 8.6
Total Revenue $17,582 $15,645 $1,937 12.4

Optex Systems Richardson revenue increased by $1.1 million or 17.5% for the nine months ended July 2, 2023 as compared to the prior year period on increased periscope delivery volume.

Applied Optics Center revenue increased by $0.8 million or 8.6% for the nine months ended July 2, 2023 as compared to the prior year period. The revenue increase is primarily attributable to higher shipment volume on optical assemblies.

Gross Margin. The gross margin during the nine-month period ended July 2, 2023 was 22.7% as compared to a gross margin of 17.9% for the prior year period. The increase in gross profit is primarily attributable to higher revenue, changes in product mix between segments and increased fixed cost absorption across a higher revenue base (on a consolidated company basis). Cost of sales increased to $13.6 million for the nine months ended July 2, 2023 as compared to the prior year period of $12.8 million on higher revenue.

G&A Expenses. During the nine months ended July 2, 2023 and July 3, 2022, we recorded operating expenses of $2.9 million and $2.5 million, respectively. Operating expenses increased by 17.1% between the respective periods primarily due to increased labor, office, legal, accounting and banking and travel expenses.

Operating Income. During the nine months ended July 2, 2023, we recorded operating income of $1.1 million, as compared to an operating income of $0.3 million during the nine months ended July 3, 2022. The $0.8 million increase in operating income is primarily due to increased revenue and gross profit, offset by higher spending in general and administrative expenses.

Liquidity and Capital Resources

As of July 2, 2023, the Company had working capital of $12.2 million, as compared to $10.0 million as of October 2, 2022.

During the nine months ended July 2, 2023, we used operating cash of ($1.4) million, borrowed a net $1.2 million against our line of credit and spent $0.4 million on acquisitions of property and equipment. During the period, our inventory increased $3.1 million in support of new program awards and increasing revenues anticipated over the next twelve months.

The Company has capital commitments of $9 thousand for the purchase of property and equipment consisting of engineering services related to an automated acrylic buffing system.

Backlog as of July 2, 2023 was $41.6 million as compared to backlog of $30.0 million as of July 3, 2022 and $32.9 million as of October 2, 2022, representing an increase of 38.7% and 26.4%, respectively. For further details, see “Results of Operations – New Orders and Backlog” above.

The Company has historically funded its operations through cash from operations, convertible notes, common and preferred stock offerings and bank debt. The Company’s ability to generate positive cash flows depends on a variety of factors, including the continued development and successful marketing of the Company’s products.

At July 2, 2023, the Company had $0.3 million in cash and an outstanding payable balance of $1.2 million against its line of credit. At July 2, 2023, our outstanding accounts receivable balance was $2.9 million. We expect the accounts to be collected during the fourth quarter of fiscal 2023.

We have experienced significant material shortages during the three months ended October 2, 2022 and extending into the first nine months of fiscal year 2023 from two significant suppliers of our periscope covers and housings. These shortages affect several of our periscope products at the Optex Richardson segment. The delays in key components, combined with labor shortages during the first nine months of fiscal year 2023, have negatively impacted our production levels and have pushed expected customer delivery dates into the first half of fiscal year 2024. We are aggressively seeking alternative sources and actively expediting our current suppliers for these components as well as increasing employee recruitment initiatives and overtime to attempt to mitigate any continuing risks to the periscope line. In addition, one of our major customers for the Applied Optics Center requested a significant schedule delay pushing their laser filter unit deliveries from the first half into the second half of fiscal year 2023. As described in more detail below, in March 2023, we entered into a new line of credit, effectively increasing our credit limit from $2.0 million to $3.0 million to facilitate our working capital requirements due to the delays and increased backlog. We are encouraged by recent improvements in supplier performance for the Optex Richardson segment periscope line which yielded increased revenue performance during the second and third quarters. However, we cannot give any assurances that expected customer delivery dates for our periscope products will not need to be delayed further.

In the short term, the Company plans to utilize its current cash, available line of credit and operating cash flow to fund inventory purchases in support of the backlog growth and higher anticipated revenue during the next twelve months. Short term cash in excess of our working capital needs may be also be used to fund the purchase of product lines and other assets, including property and equipment required to maintain or meet our growing backlog, in addition to repurchasing common stock against our current stock repurchase plan. Longer term, excess cash beyond our operating needs may be used to fund new product development, company or product line acquisitions, or additional stock purchases as attractive opportunities present themselves.

In some instances, new government contract awards may allow for contract financing in the form of progress payments pursuant to Federal Acquisition Regulation 52.232-16, “Progress Payments.” Subject to certain limitations, this clause provides for government payment of up to 90% of incurred program costs prior to product delivery for small businesses like us. To the extent any contracts allow for progress payments and the respective contracts would result in significant preproduction cash requirements for design, process development, tooling, material or other resources which could exceed our current working capital or line of credit availability, we intend to utilize this benefit to minimize any potential negative impact on working capital prior to receipt of payment for the associated contract deliveries. Currently none of our existing contracts allow for progress payments.

We refer to “Note 4 – Commitments and Contingencies – Non-cancellable Operating Leases” for a tabular depiction of our remaining minimum lease and estimated CAM payments under such leases as of July 2, 2023, which disclosure is incorporated herein by reference.

The Company expects to generate net income and positive cash flow from operating activities over the next twelve months. To achieve and retain profitability, we need to maintain a level of revenue adequate to support our cost structure. Management intends to manage operations commensurate with its level of working capital and line of credit during the next twelve months and beyond; however, uneven revenue levels driven by changes in customer delivery demands, first article inspection requirements or other program delays associated with the pandemic, labor shortages and supply chain issues could create a working capital shortfall. In the event the Company does not successfully implement its ultimate business plan, certain assets may not be recoverable.

On March 22, 2023, the Company and its subsidiary, Optex Systems, Inc. (“Optex”, and with the Company, the “Borrowers”), entered into a Business Loan Agreement (the “Loan Agreement”) with Texas Capital Bank (the “Lender”), pursuant to which the Lender will make available to the Borrowers a revolving line of credit in the principal amount of $3 million (the “Credit Facility”). The commitment period for advances under the Credit Facility is twenty-six months expiring on May 22, 2025. We refer to the expiration of that time period as the “Maturity Date.” Outstanding advances under the Credit Facility will accrue interest at a rate equal to the secured overnight financing rate (SOFR) plus a specified margin, subject to a specified floor interest rate. The interest rate is currently at 7.827% per annum.

The Loan Agreement contains customary events of default (including a 25% change in ownership) and negative covenants, including but not limited to those governing indebtedness, liens, fundamental changes (including changes in management), investments, and restricted payments (including cash dividends). The Loan Agreement also requires the Borrowers to maintain a fixed charge coverage ratio of at least 1.25:1 and a total leverage ratio of 3.00:1. The Credit Facility is secured by substantially all of the operating assets of the Borrowers as collateral. The Borrowers’ obligations under the Credit Facility are subject to acceleration upon the occurrence of an event of default as defined in the Loan Agreement. The Loan Agreement further provides for a $125,000 Letter of Credit sublimit. As of July 2, 2023, there was $1.2 million borrowed under the Credit Facility. As of July 2, 2023, the Company is in compliance with all covenants under the Credit Facility.

The Credit Facility replaced the prior $2 million line of credit with PNC Bank, National Association.

On September 22, 2021 the Company announced authorization for an additional $1 million stock repurchase program. As of July 2, 2023, there was an authorized balance of $560 thousand remaining to be spent against the repurchase program. During the nine months ended July 2, 2023, there were no stock repurchases against the plan.

Critical Accounting Estimates

A critical accounting estimate is an estimate that:

  • is made in accordance with generally accepted accounting principles,
  • involves a significant level of estimation uncertainty, and
  • has had or is reasonably likely to have a material impact on the company’s financial condition or results of operation.

Our significant accounting policies are fundamental to understanding our results of operations and financial condition. Some accounting policies require that we use estimates and assumptions that may affect the value of our assets or liabilities and financial results. These policies are described in “Critical Policies and Accounting Pronouncements” and Note 2 (Accounting Policies) to consolidated financial statements in our Annual Report on Form 10-K for the year ended October 2, 2022.

Our critical accounting estimates include warranty costs, contract losses and the deferred tax asset valuation. Future warranty costs are based on the estimated cost of replacement for expected returns based upon our most recent experience rate of defects as a percentage of warranty covered sales. Our warranty covered sales primarily include the Applied Optics Center optical assemblies. While our warranty period is 12 months, our reserve balances assume a general 90-day return period for optical assemblies previously delivered plus any returned backlog in-house that has not yet been repaired or replaced to our customer. If our actual warranty returns should significantly exceed our historical rates on new customer products, significant production changes, or substantial customer changes to the 90-day turn-around times on returned goods, the impact could be material to our operating profit. We have not experienced any significant changes to our warranty trends in the preceding three years and do not anticipate any significant impacts in the near term. We monitor the actual warranty costs incurred to the expected values on a quarterly basis and adjust our estimates accordingly. As of July 2, 2023, the Company had accrued warranty costs of $241 thousand, as compared to $169 thousand as of October 2, 2022. The primary reason for the $72 thousand increase in reserve balances relates to higher revenue on warrantied product being sold during the nine months ended July 2, 2023 as compared to the prior year resulting in increased backlog on returned products.

As of July 2, 2023 and October 2, 2022, we had $133 thousand, and $289 thousand, respectively, of contract loss reserves included in our balance sheet accrued expenses. These loss contracts are related to some of our older legacy periscope IDIQ contracts which were priced in 2018 through early 2020, prior to Covid-19 and the significant downturn in defense spending on ground system vehicles. Due to inflationary price increases on component parts and higher internal manufacturing costs (as a result of escalating labor costs and higher burden rates on reduced volume), some of these contracts are in a loss condition, or at marginal profit rates. These contracts are typically three-year IDIQ contracts with two optional award years, and as such, we are obligated to accept new task awards against these contracts until the contract expiration. Should contract costs continue to increase above the negotiated selling price, or in the event the customer should release substantial quantities against these existing loss contracts, the losses could be material. For contracts currently in a loss status based on the estimated per unit contract costs, losses are booked immediately on new task order awards. During the nine months ended July 2, 2023, accrued contract losses decreased $156 thousand due to shipments against contract backlog and improvements in the total estimated contract costs associated with higher revenue and improved manufacturing overhead rates on increased production levels. There is no way to reasonably estimate future inflationary impacts, or customer awards on the existing loss contracts.

As of July 2, 2023 and October 2, 2022, Optex Systems, Inc. has a deferred tax asset valuation allowance of ($0.8) million against deferred tax assets of $1.6 million and $1.8 million, respectively, for a net deferred tax asset of $0.8 million and $1.0 million. During the nine months ended July 2, 2023, our deferred tax assets decreased by $0.2 million related to temporary tax adjustments. The valuation allowance covers certain deferred tax assets where we believe we will be unlikely to recover those tax assets through future operations. The valuation reserve includes assumptions related to future taxable income which would be available to cover net operating loss carryforward amounts. Because of the uncertainties of future income forecasts combined with the complexity of some of the deferred assets, these forecasts are subject to change over time. While we believe our current estimate to be reasonable, changing market conditions and profitability, changes in equity structure and changes in tax regulations may impact our estimated reserves in future periods.

Controls and procedures

As filed, 1,392 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by our Quarterly Report on Form 10-Q for the quarter ended July 2, 2023, management performed, with the participation of our Principal Executive Officer and Principal Financial Officer, an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s forms, and that such information is accumulated and communicated to our management including our Principal Executive Officer and our Principal Financial Officer, to allow timely decisions regarding required disclosures. Based upon the evaluation described above, our Principal Executive Officer and our Principal Financial Officer concluded that, as of July 2, 2023, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

During the three months ended July 2, 2023, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 2,731 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We have added the following risk factor due to recent events impacting regional banks. There have been no other material changes in the risk factors set forth in the Form 10-K filed for the year ended October 2, 2022.

Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our business, results of operations or financial condition.

Events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as receiver; on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership; and on May 1, 2023, First Republic Bank failed and regulators sold substantially all of its assets to JPMorgan Chase & Co. The failure of First Republic Bank occurred despite a previous attempt by some of the nation’s largest banks to shore up First Republic’s capital. Although we assess our banking and customer relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impacted.

In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or other obligations, result in breaches of our contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our business, results of operations or financial condition.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-07-02. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-04-03 to 2023-07-02$7.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-10-03 to 2023-07-02$17.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2023-04-03 to 2023-07-02$5.5mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2022-10-03 to 2023-07-02$13.6mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2023-04-03 to 2023-07-02$1.7mus-gaap:GrossProfit
Gross profit9 months2022-10-03 to 2023-07-02$4.0mus-gaap:GrossProfit
Operating income3 months2023-04-03 to 2023-07-02$752.0kus-gaap:OperatingIncomeLoss
Operating income9 months2022-10-03 to 2023-07-02$1.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-04-03 to 2023-07-02$22.0kus-gaap:InterestExpense
Interest expense9 months2022-10-03 to 2023-07-02$31.0kus-gaap:InterestExpense
Income tax3 months2023-04-03 to 2023-07-02$154.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-10-03 to 2023-07-02$223.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-04-03 to 2023-07-02$576.0kus-gaap:NetIncomeLoss
Net income9 months2022-10-03 to 2023-07-02$832.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2023-04-03 to 2023-07-02$0.09us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-10-03 to 2023-07-02$0.13us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-04-03 to 2023-07-02$0.09us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-10-03 to 2023-07-02$0.13us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-04-03 to 2023-07-026,686,211 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-10-03 to 2023-07-026,642,604 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-10-03 to 2023-07-02−$1.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2023-04-03 to 2023-07-02$222.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Capital expenditure9 months2022-10-03 to 2023-07-02$368.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2023-07-02$314.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-07-02$16.2mus-gaap:AssetsCurrent
Total assetsAt period end2023-07-02$21.0mus-gaap:Assets
Current liabilitiesAt period end2023-07-02$4.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-07-02$7.6mus-gaap:Liabilities
Shareholders' equityAt period end2023-07-02$13.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-23-029153. Last ingested by Listed: Nov 14, 2026, 11:39 ET. Listed shows no prices and gives no investment advice.